Showing results (41-50 of 451) with videos related to
Sort By:
Pageof 46
Arthritis & Rheumatology (Hoboken, N.J.)|March 5, 2014
Prediction of pulmonary complications and long-term survival in systemic sclerosisSvetlana I Nihtyanova, Benjamin E Schreiber, Voon H Ong, et al.Arthritis & Rheumatology (Hoboken, N.J.)|November 5, 2019
Using Autoantibodies and Cutaneous Subset to Develop Outcome-Based Disease Classification in Systemic SclerosisSvetlana I Nihtyanova, Alper Sari, Jennifer C Harvey, et al.Rheumatology (Oxford, England)|January 3, 2025
Tocilizumab and rituximab for systemic sclerosis interstitial lung disease: a real-world cohort analysisNina R Goldman, Svetlana I Nihtyanova, Claire F Beesley, et al.Annals of the Rheumatic Diseases|June 2, 2018
Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosisChristopher P Denton, Voon H Ong, Shiwen Xu, et al.The European Respiratory Journal|January 28, 2012
Severe interstitial lung disease in connective tissue disease: rituximab as rescue therapyGregory J Keir, Toby M Maher, David M Hansell, et al.Rheumatology (Oxford, England)|September 9, 2025
Impact of hand function impairment on daily life of patients with systemic sclerosis: a qualitative studyMark Greveling, Stefano Rodolfi, Nora El Bardai, et al.Arthritis & Rheumatology (Hoboken, N.J.)|December 2, 2017
Association of Defective Regulation of Autoreactive Interleukin-6-Producing Transitional B Lymphocytes With Disease in Patients With Systemic SclerosisTaher E Taher, Voon H Ong, Jonas Bystrom, et al.Annals of the Rheumatic Diseases|July 6, 2023
Clinical and pathogenic significance of S100A4 overexpression in systemic sclerosisChristopher P Denton, Shiwen Xu, Fenge Zhang, et al.Rheumatology (Oxford, England)|October 14, 2024
Self-reported skin severity and quality of life in systemic sclerosis: multicentre validation of PASTULJulia Spierings, Paco M J Welsing, Seda Colak, et al.Nature Reviews. Rheumatology|August 5, 2026
Navigating evidence-based recommendations for the management of systemic sclerosisFrancesco Del Galdo, Yannick Allanore, Oliver Distler, et al.Pageof 46